Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum-Reference-Cited by-同舟云学术

Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum

Published:2023-02 Issue: Volume:643 Page:129-138
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Aggarwal Savera,Yadav Vipin,Maiwall Rakhi,Rastogi Archana,Pamecha Viniyendra,Bedi Onkar,Maras Jaswinder Singh,Trehanpati Nirupma,Ramakrishna Gayatri

Funder

Department of Science and Technology, Ministry of Science and Technology, India

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference33 articles.

1. Nonalcoholic fatty liver disease: Indian perspective;De;Clin. Liver Dis.(Hoboken),2021

2. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update;El-Serag;Ann. Intern. Med.,2003

3. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer,2016

4. MAFLD: a ConsensusDriven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020

5. Nomenclature and definition of metabolicassociated fatty liver disease: a consensus from the Middle East and north Africa;Shiha;Lancet Gastroenterol. Hepatol.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroimaging and Biomarkers in AD Detection;Advances in Medical Technologies and Clinical Practice;2024-06-28

2. Molecular mechanism and therapeutic significance of essential amino acids in metabolically associated fatty liver disease;The Journal of Nutritional Biochemistry;2024-04

3. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma;Nature Communications;2023-10-12

4. Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease;Scandinavian Journal of Gastroenterology;2023-06-20

5. Therapeutic application of natural products: NAD+ metabolism as potential target;Phytomedicine;2023-06